Village doctors are being placed at the center of lung cancer screening delivery in rural China
Lung cancer remains the most frequently diagnosed cancer and the leading cause of cancer-related death worldwide, and China continues to face a steady climb in both incidence and mortality. Against that backdrop, a protocol in BMJ Open sets out a mixed-methods evaluation of a village doctor-led implementation strategy for lung cancer screening in rural China. The design is not a screening efficacy trial in the narrow sense; it is a study of how screening can actually be delivered in routine primary care settings where access, workflow, behavior, and local context shape what reaches patients.
The protocol uses a positive deviance approach, which means the evaluation is built around identifying successful practices already occurring within the system and learning from them rather than assuming one universal solution will fit every village clinic. In practical terms, that is a useful choice for rural China, where village doctors occupy a frontline position and the feasibility of any evidence-based screening program depends on whether those clinicians can recognize risk, communicate with patients, and sustain referrals within the constraints of primary care practice.
Why implementation, not just evidence, determines screening reach
The abstract frames a familiar clinical problem in an especially concrete way: even when a cancer screening strategy is evidence-based, uptake and fidelity can collapse if the delivery model does not match the realities of the setting. Rural communities often face gaps in specialist access, uneven health literacy, and the logistical burden of moving from case identification to definitive evaluation. In that setting, the village doctor is not a peripheral actor. The village doctor is the delivery point.
This protocol focuses on the behavioral and contextual determinants that influence implementation. The emphasis matters because screening programs do not fail only from lack of scientific validity; they also fail when clinicians lack time, confidence, incentives, or workable procedures. A village doctor-led strategy may succeed if it aligns with existing patient relationships, local trust, and primary care workflows. It may fail if referral pathways are opaque or if screening conversations are too complex to sustain during ordinary clinic visits.
China’s rising lung cancer burden makes that question especially urgent. From 1990 to 2021, the age-standardized incidence and mortality rates in the overall population increased, and the article opens with global 2024 figures that reinforce the scale of the problem. Those numbers are not decorative epidemiology. They explain why implementation science has become central to cancer control in settings where screening must be extended beyond urban tertiary centers.
Mixed methods are being used to map behavior, context, and preference
The protocol combines methods rather than relying on one lens alone. Qualitative work will be used to identify contextual and behavioral determinants of implementation, capturing the practical barriers and facilitators that shape how village doctors and other stakeholders engage with lung cancer screening. Quantitative components are designed to add structure to those findings, including best-worst scaling to measure stakeholder preferences and help refine tailored implementation strategies.
That combination is well suited to a primary care intervention where attitudes, feasibility, and workflow all matter at once. Best-worst scaling can force priorities into sharper relief than an open-ended discussion alone, revealing which implementation features are valued most and which are likely to be ignored when resources are limited. In a rural screening program, those preferences may influence whether screening is framed as a routine preventive task, a referral process, or a broader community health activity.
A retrospective evaluation without real-time observation is one of the stated limitations. That restriction matters because implementation problems often unfold in the moment: a patient hesitates, a clinician shortens counseling, a referral pathway stalls, or a workflow workaround becomes the default. Retrospective data can still illuminate patterns, but it cannot fully capture the minute-by-minute friction of clinical practice. Real-world screening delivery is often decided in those small interactions.
Positive deviance turns local success into implementation strategy
The positive deviance framework is the most distinctive feature of the protocol. Rather than treating rural implementation as a blanket problem, it looks for villages, clinicians, or workflows that are already performing better under the same broad constraints. That approach assumes useful variation exists inside the system and that successful practices can be studied, interpreted, and adapted.
For lung cancer screening, this is more than a methodological preference. Screening programs depend on repeated micro-decisions: who gets identified, how risk is explained, whether a patient accepts follow-up, and whether the clinic can keep the process moving. If certain village doctors are already navigating those steps more effectively, the reasons may be behavioral, relational, or organizational rather than purely clinical. A positive deviance design is built to find those reasons.
The protocol also promises practical implications for optimizing and scaling evidence-based screening in primary care. In plain terms, the study is trying to identify what makes screening workable in the places where most patients first seek care. If successful, the findings could inform how screening responsibilities are assigned, how clinicians are trained, and how implementation strategies are tailored to rural settings rather than imported wholesale from urban systems.
What the protocol can and cannot answer yet
Because this is a protocol, it does not provide outcome data on screening uptake, cancer detection, or survival. It also does not establish whether the village doctor-led strategy will outperform other delivery models. What it does offer is a detailed plan to study the conditions under which such a strategy is likely to function, and to do so with attention to the people actually carrying it out.
The emphasis on mixed methods is appropriate for a question that sits at the intersection of oncology, primary care, and health services research. Lung cancer screening can only reduce harm if the system around it is built to recognize risk and move patients forward efficiently. In rural China, that system begins with village doctors, and this protocol is designed to examine what helps them succeed, what holds them back, and which practices deserve to be carried forward as screening programs expand.
The next meaningful evidence will not come from the protocol itself but from the evaluation it sets in motion: whether the identified implementation determinants truly explain variation in performance, and whether the resulting strategy can be translated into broader rural practice without losing fidelity or reach.